Sanofi SA Looks Like One Of The Better Bargains In Big Pharma
Sanofi's diverse pipeline is a marked contrast to many Big Pharma peers.
Reflections on the Biotech Earnings Bonanza: LLY, NVO, GILD
A look at some of top names in biotech show that the sector is still growing and 2014 could be another banner year.
Eli Lilly & Co.: Cymbalta Sales Slide Begins
Eli Lilly's top selling drug has lost patent protection, making this an important transition year for the company.